FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Deeks

Research Profile

Disorders

Living Beings

HIV-1
HIV

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Stéphane Champiat; Steven G Deeks; Keith E Garrison; Fredrick M Hecht; Jeffrey N Martin; Laura P Newman; Francesca A Nimityongskul; Mario A Ostrowski; Christopher D Pilcher; Rui André Saraiva Raposo; Jason Reed; Michael G Rosenberg; Jonah B Sacha; Gerald Spotts; Ravi Tandon; Nancy A Wilson; Andrew Wiznia; Vanessa A York; Rafael R Almeida; Benjamin J Burwitz; Douglas F Nixon
T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques.
Edwin Leeansyah; Jeffrey N Martin; Markus Moll; Máire F Quigley; Jan Andersson; Steven G Deeks; Anupama Ganesh; Peter W Hunt; Barbara L Shacklett; Ma Somsouk; Anders Sönnerborg; Johan K Sandberg
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.
Richard M Dunham; Genoveffa Franchini; Shari N Gordon; Yong Huang; Jeffrey Lifson; Michael Piatak; Monica Vaccari; Steven G Deeks; Joseph M McCune
Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Deeks (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stéphane Champiat; Steven G Deeks; Keith E Garrison; Fredrick M Hecht; Jeffrey N Martin; Laura P Newman; Francesca A Nimityongskul; Mario A Ostrowski; Christopher D Pilcher; Rui André Saraiva Raposo; Jason Reed; Michael G Rosenberg; Jonah B Sacha; Gerald Spotts; Ravi Tandon; Nancy A Wilson; Andrew Wiznia; Vanessa A York; Rafael R Almeida; Benjamin J Burwitz; Douglas F Nixon
T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques.
Journal of virology 2013;87(11):6073-80.
2013: Edwin Leeansyah; Jeffrey N Martin; Markus Moll; Máire F Quigley; Jan Andersson; Steven G Deeks; Anupama Ganesh; Peter W Hunt; Barbara L Shacklett; Ma Somsouk; Anders Sönnerborg; Johan K Sandberg
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.
Blood 2013;121(7):1124-35.
2013: Richard M Dunham; Genoveffa Franchini; Shari N Gordon; Yong Huang; Jeffrey Lifson; Michael Piatak; Monica Vaccari; Steven G Deeks; Joseph M McCune
Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase.
AIDS research and human retroviruses 2013;29(2):207-14.
2013: Livio Azzoni; Michael P Busch; Mary Carrington; Steven G Deeks; Andrea S Foulkes; Ian Frank; Jeffrey M Jacobson; Jay R Kostman; Kenneth M Lynn; Angela M Mexas; Karam Mounzer; Una O'Doherty; Emmanouil Papasavvas; Pablo Tebas; Luis J Montaner
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.
The Journal of infectious diseases 2013;207(2):213-22.
2013: Julia M Shaw; Ma Somsouk; J William Critchfield; Steven G Deeks; Juan Carlos Garcia; Peter W Hunt; Delandy H McConnell; Richard B Pollard; Barbara L Shacklett
Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.
AIDS research and human retroviruses 2013;29(1):172-7.
2012: Elvin H Geng; C Bradley Hare; Katerina A Christopoulos; Steven G Deeks; Monica Gandhi; Vivek Jain; James O Kahn; Tracy Van Nunnery; Diane V Havlir
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(12):1690-7.
2012: Steven G Deeks; Rajesh T Gandhi; Claudia U Chae; Kent B Lewandrowski
Case records of the Massachusetts General Hospital. Case 30-2012. A 54-year-old woman with HIV infection, dyspnea, and chest pain.
The New England journal of medicine 2012;367(13):1246-54.
2012: Costin Tomescu; Anne Viviani; Mary Carrington; Steven G Deeks; Fuh-Mei Duh; Kara Harvill; Rebecca Hoh; Maureen P Martin; Luis J Montaner
Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers.
AIDS (London, England) 2012;26(15):1869-78.
2012: Steven G Deeks
HIV infection, lymphoid fibrosis, and disease.
Blood 2012;120(9):1753-4.
2012: Steven G Deeks; Eric Verdin; Joseph M McCune
Immunosenescence and HIV.
Current opinion in immunology 2012;24(4):501-6.
2012: Steven G Deeks; Françoise Barré-Sinoussi
Public health: Towards a cure for HIV.
Nature 2012;487(7407):293-4.
2012: John Scholler; Ashley N Vogel; Michael Kalos; Bruce L Levine; Ronald T Mitsuyasu; Gabriela Plesa; James L Riley; Naomi E Aronson; Wendy B Bernstein; Gwendolyn Binder-Scholl; Troy L Brady; Frederic D Bushman; Steven G Deeks; Kristen M Hege; Wei-Ting Hwang; Carl H June
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.
Science translational medicine 2012;4(132):132ra53.
2012: Priscilla Y Hsue; Peter W Hunt; S C Kalapus; Kristinalisa Maka; Jeffrey N Martin; Rebecca Scherzer; Audrey H Schnell; Ann F Bolger; Peter Ganz; Steven G Deeks
Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation.
Journal of the American Heart Association 2012;1(2):.
2012: Priscilla Y Hsue; Louis P Kohl; Jeffrey N Martin; Elaine Nitta; Sarah M Nordstrom; Rebecca Scherzer; Audrey H Schnell; Steven G Deeks; Carl Grunfeld; Ethan J Weiss
HIV infection is associated with decreased thrombin generation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(8):1196-203.
2012: Priscilla Y Hsue; Theodore Lee; Erin Madden; Jeffrey N Martin; Karen Ordovas; Gautham Reddy; Audrey H Schnell; Van Selby; Steven G Deeks; Peter Ganz; Michael Gotway; Jennifer E Ho; David D Waters
Carotid intima-media thickness among human immunodeficiency virus-infected patients without coronary calcium.
The American journal of cardiology 2012;109(5):742-7.
2012: Haoyan Chen; Steven G Deeks; Alexander Dilthey; Marcelo A Fernandez Vina; Genki Hayashi; Peter J Kuebler; Olivia Y Lai; Kieron S Leslie; Jeffrey N Martin; Maureen P Martin; Toby Maurer; Gil McVean; Douglas F Nixon; Matthias Wabl; Tami V Wong; Anne M Bowcock; Mary Carrington; Wilson Liao
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.
PLoS genetics 2012;8(2):e1002514.
2012: Emily M Eriksson; Frederick M Hecht; Emily L Ho; Sara J Holditch; Peter W Hunt; Sheila M Keating; Chris E Keh; Jeffrey N Martin; Jeffrey M Milush; Mariana D Batista; Steven G Deeks; Philip J Norris; Michael G Rosenberg; Douglas F Nixon
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
Blood 2012;119(3):745-55.
2012: Emily M Eriksson; Frederick M Hecht; Chris E Keh; Jeffrey N Martin; Steven G Deeks; Douglas F Nixon
Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.
PloS one 2012;7(12):e51696.
2012: Adam S Lauring; Tzong-Hae Lee; Jeffrey N Martin; Steven G Deeks; Peter W Hunt; Michael Busch
Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection.
PloS one 2012;7(11):e50486.
2012: Stephane Champiat; Hansi Dean; Steven G Deeks; Keith E Garrison; Aaron M Hasenkrug; Fredrick M Hecht; Marisa Ailin Hong; Esper Kallas; Wayne C Koff; John L Lehman; Nicholas J Maness; Jeffrey N Martin; Jacob C Miller; Christopher D Pilcher; Sean E Purtell; Rui André Saraiva Raposo; Gerald Spotts; Douglas F Nixon
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.
PloS one 2012;7(6):e39311.
2011: Peter W Hunt; Annet Kembabazi; Conrad Muzoora; Torsten B Neilands; Isaac Ssewanyana; David R Bangsberg; John Bennett; Huyen L Cao; Steven G Deeks; Nneka Emenyonu; Jeffrey N Martin
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
AIDS (London, England) 2011;25(17):2123-31.
2011: Elvin H Geng; C Bradley Hare; Diane V Havlir; Diane Jones; James S Kahn; Maya L Petersen; Olivia C Chang; Katerina A Christopoulos; Steven G Deeks; Monica Gandhi
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(10):1008-14.
2011: Julia M Shaw; Ma Somsouk; J William Critchfield; Steven G Deeks; Juan Carlos Garcia; Peter W Hunt; Delandy H McConnell; Richard B Pollard; Barbara L Shacklett
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
Journal of virology 2011;85(21):11422-34.
2011: Timothy R Sterling; Jennifer E Thorne; James H Willig; Jinbing Zhang; Ronald J Bosch; John T Brooks; Steven G Deeks; Joseph J Eron; Aimee Freeman; Audrey French; Stephen J Gange; Kelly A Gebo; James J Goedert; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; M John Gill; Amy C Justice; Gregory D Kirk; Mari M Kitahata; Marina B Klein; Bryan Lau; Jeffrey N Martin; Rosemary G McKaig; Richard D Moore; Sonia Napravnik; Benigno Rodriguez; Michael J Silverberg
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
The Journal of infectious diseases 2011;204(6):893-901.
2011: Steven A Yukl; Steven G Deeks; Katsuya Fujimoto; C Bradley Hare; Diane V Havlir; Harry Lampiris; Peilin Li; Teri Liegler; Chuanyi M Lu; Mark Pandori; Joseph Wong
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.
Journal of virological methods 2011;175(2):261-5.
2011: Devi SenGupta; Gerald Spotts; Ravi Tandon; Raphaella G S Vieira; Vanessa A York; Christopher E Ormsby; Mario A Ostrowski; Gustavo Reyes-Terán; Steven G Deeks; Keith E Garrison; Frederick M Hecht; R Brad Jones; Liyen Loh; Rachel Lown-Hecht; Jeffrey N Martin; Lishomwa C Ndhlovu; Douglas F Nixon
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
Journal of virology 2011;85(14):6977-85.
2011: Peter Bacchetti; Steven G Deeks; Joseph M McCune
Breaking free of sample size dogma to perform innovative translational research.
Science translational medicine 2011;3(87):87ps24.
2011: Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Lorrie Epling; Juli Teague; Mark A Jacobson; Russell P Tracy; Lawrence Corey; Steven G Deeks
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.
The Journal of infectious diseases 2011;203(10):1474-83.
2011: Vivek Jain; Maria C Sucupira; Peter Bacchetti; Wendy Hartogensis; Ricardo S Diaz; Esper Kallas; Luiz M Janini; Teri Liegler; Christopher D Pilcher; Robert M Grant; Rodrigo Cortes; Steven G Deeks; Frederick M Hecht
Differential persistence of transmitted HIV-1 drug resistance mutation classes.
The Journal of infectious diseases 2011;203(8):1174-81.
2011: Hiroyu Hatano; Timothy L Hayes; Viktor Dahl; Elizabeth Sinclair; Tzong-Hae Lee; Rebecca Hoh; Harry Lampiris; Peter W Hunt; Sarah Palmer; Joseph M McCune; Jeffrey N Martin; Michael P Busch; Barbara L Shacklett; Steven G Deeks
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.
The Journal of infectious diseases 2011;203(7):960-8.
2011: Andy I Choi; Joan C Lo; Kathleen Mulligan; Audrey H Schnell; S Craig Kalapus; Yongmei Li; Peter W Hunt; Jeffrey N Martin; Steven G Deeks; Priscilla Y Hsue
Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(7):941-4.
2011: David Favre; Cheryl A Stoddart; Brinda Emu; Rebecca Hoh; Jeffrey N Martin; Frederick M Hecht; Steven G Deeks; Joseph M McCune
HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.
Blood 2011;117(7):2189-99.
2011: Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Katerina A Christopoulos; Steven G Deeks; Nneka Emenyonu; Nicolas Musinguzi; Winnie Muyindike; Torsten B Neilands; Constantin T Yiannoutsos; Jeffrey N Martin
Retention in care and connection to care among HIV-infected patients on antiretroviral therapy in Africa: estimation via a sampling-based approach.
PloS one 2011;6(7):e21797.
2011: Christina M R Kitchen; Jeffrey N Martin; Joseph M McCune; Elizabeth Sinclair; Lilit Yeghiazarian; Rebecca Hoh; Steven G Deeks
Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection.
PloS one 2011;6(6):e21190.
2011: Peter W Hunt; Alan L Landay; Elizabeth Sinclair; Jeffrey A Martinson; Hiroyu Hatano; Brinda Emu; Philip J Norris; Michael P Busch; Jeffrey N Martin; Cicely Brooks; Joseph M McCune; Steven G Deeks
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.
PloS one 2011;6(1):e15924.
2011: Steven G Deeks
HIV infection, inflammation, immunosenescence, and aging.
Annual review of medicine 2011;62():141-55.
2010: David R Bangsberg; Kathleen Ragland; Alex Monk; Steven G Deeks
A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people.
AIDS (London, England) 2010;24(18):2835-40.
2010: Hiroyu Hatano; Eric L Delwart; Philip J Norris; Tzong-Hae Lee; Torsten B Neilands; Colleen F Kelley; Peter W Hunt; Rebecca Hoh; Jeffrey M Linnen; Jeffrey N Martin; Michael P Busch; Steven G Deeks
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals.
AIDS (London, England) 2010;24(16):2535-9.
2010: Steven G Deeks; Joseph M McCune
Can HIV be cured with stem cell therapy?
Nature biotechnology 2010;28(8):807-10.
2010: Hiroyu Hatano; Harry Lampiris; Signe Fransen; Soumi Gupta; Wei Huang; Rebecca Hoh; Jeffrey N Martin; Jacob Lalezari; david bangsberg; Christos Petropoulos; Steven G Deeks
Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2010;54(4):389-93.
2010: Paul A Volberding; Steven G Deeks
Antiretroviral therapy and management of HIV infection.
Lancet 2010;376(9734):49-62.
2010: Elvin H Geng; David V Glidden; Nneka Emenyonu; Nicolas Musinguzi; Mwebwesa Bosco Bwana; Torsten B Neilands; Winnie Muyindike; Constantin T Yiannoutsos; Steven G Deeks; David R Bangsberg; Jeffrey N Martin
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.
Tropical medicine & international health : TM & IH 2010;15 Suppl 1():63-9.
2010: David Favre; Jeff Mold; Peter W Hunt; Bittoo Kanwar; P'ng Loke; Lillian Seu; Jason D Barbour; Margaret M Lowe; Anura Jayawardene; Francesca T Aweeka; Yong Huang; Daniel C Douek; Jason M Brenchley; Jeffrey N Martin; Frederick Hecht; Steven G Deeks; Joseph M McCune
Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.
Science translational medicine 2010;2(32):32ra36.
2010: Rachel E Owen; John W Heitman; Dale F Hirschkorn; Marion C Lanteri; Hope H Biswas; Jeffrey N Martin; Melissa R Krone; Steven G Deeks; Philip J Norris
HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
AIDS (London, England) 2010;24(8):1095-105.
2010: John C Probasco; Steven G Deeks; Evelyn Lee; Rebecca Hoh; Peter W Hunt; Teri Liegler; Richard W Price; Serena S Spudich
Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation.
AIDS (London, England) 2010;24(7):1001-5.
2010: Elvin H Geng; David R Bangsberg; Nicolas Musinguzi; Nneka Emenyonu; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; David V Glidden; Steven G Deeks; Jeffrey N Martin
Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.
Journal of acquired immune deficiency syndromes (1999) 2010;53(3):405-11.
2010: David M Naeger; Jeffrey N Martin; Elizabeth Sinclair; Peter W Hunt; David R Bangsberg; Frederick Hecht; Priscilla Y Hsue; Joseph M McCune; Steven G Deeks
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.
PloS one 2010;5(1):e8886.
2010: Priscilla Y Hsue; Peter W Hunt; Jennifer E Ho; Husam H Farah; Amanda Schnell; Rebecca Hoh; Jeffrey N Martin; Steven G Deeks; Ann F Bolger
Impact of HIV infection on diastolic function and left ventricular mass.
Circulation. Heart failure 2010;3(1):132-9.
2009: Steven G Deeks; Stephen J Gange; Mari M Kitahata; Michael S Saag; Amy C Justice; Hogg Robert; Joseph J Eron; John T Brooks; Sean B Rourke; M John Gill; Ronald J Bosch; Constance A Benson; Ann C Collier; Jeffrey N Martin; Marina B Klein; Lisa P Jacobson; Benigno Rodriguez; Timothy R Sterling; Gregory D Kirk; Sonia Napravnik; Anita R Rachlis; Liviana M Calzavara; Michael A Horberg; Michael J Silverberg; Kelly A Gebo; Margot B Kushel; James J Goedert; Rosemary G McKaig; Richard D Moore
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1582-90.
2009: Aashish R Jha; Satish K Pillai; Vanessa A York; Elizabeth R Sharp; Emily C Storm; Douglas J Wachter; Jeffrey N Martin; Steven G Deeks; Michael G Rosenberg; Douglas F Nixon; Keith E Garrison
Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.
Molecular biology and evolution 2009;26(11):2617-26.
2009: Jennifer E Snyder-Cappione; Christopher P Loo; Karina I Carvalho; Carlotta Kuylenstierna; Steven G Deeks; Frederick Hecht; Michael G Rosenberg; Johan K Sandberg; Esper Kallas; Douglas F Nixon
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.
AIDS (London, England) 2009;23(15):1965-70.
2009: Priscilla Y Hsue; Peter W Hunt; Yuaner Wu; Amanda Schnell; Jennifer E Ho; Hiroyu Hatano; Yu Xie; Jeffrey N Martin; Peter Ganz; Steven G Deeks
Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients.
AIDS (London, England) 2009;23(15):2021-7.
2009: Steven G Deeks
Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.
Topics in HIV medicine : a publication of the International AIDS Society, USA 2009;17(4):118-23.
2009: Keith E Garrison; Stephane Champiat; Vanessa A York; Ashish T Agrawal; Esper Kallas; Jeffrey N Martin; Frederick Hecht; Steven G Deeks; Douglas F Nixon
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.
Clinical and vaccine immunology : CVI 2009;16(9):1369-71.
2009: Priscilla Y Hsue; Peter W Hunt; Audrey H Schnell; S Craig Kalapus; Rebecca Hoh; Peter Ganz; Jeffrey N Martin; Steven G Deeks
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis.
AIDS (London, England) 2009;23(9):1059-67.
2009: xavier contreras; Marc Schweneker; Ching-Shih Chen; Joseph M McCune; Steven G Deeks; Jeffrey Martin; B Matija Peterlin
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells.
The Journal of biological chemistry 2009;284(11):6782-9.
2009: Michael Rosenblum; Steven G Deeks; Mark van der Laan; David R Bangsberg
The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.
PloS one 2009;4(9):e7196.
2009: Mark A Jacobson; Dirk P Ditmer; Elizabeth Sinclair; Jeffrey N Martin; Steven G Deeks; Peter Hunt; Edward Mocarski; Caroline Shiboski
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients.
PloS one 2009;4(4):e5277.
2009: Steven G Deeks; Andrew N Phillips
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
BMJ (Clinical research ed.) 2009;338():a3172.
2008: Vincent Marconi; Sebastian Bonhoeffer; Roger Paredes; Jing Lu; Rebecca Hoh; Jeffery N Martin; Steven G Deeks; Daniel R Kuritzkes
Viral dynamics and in vivo fitness of HIV-1 in the presence and absence of enfuvirtide.
Journal of acquired immune deficiency syndromes (1999) 2008;48(5):572-6.
2008: J C Probasco; Serena S Spudich; J Critchfield; E Lee; Nicole Lollo; Steven G Deeks; Richard W Price
Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study.
Neurology 2008;71(7):521-4.
2008: Steven G Deeks
Transmitted minority drug-resistant HIV variants: a new epidemic?
PLoS medicine 2008;5(7):e164.
2008: Brinda Emu; Elizabeth Sinclair; Hiroyu Hatano; April Ferre; Barbara L Shacklett; Jeffrey N Martin; Joseph M McCune; Steven G Deeks
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
Journal of virology 2008;82(11):5398-407.
2008: Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
HIV-induced changes in T cell signaling pathways.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(10):6490-500.
2008: Priscilla Y Hsue; Steven G Deeks; Husam H Farah; Swapna Palav; Samira Y Ahmed; Amanda Schnell; Allison B Ellman; Laurence Huang; Sheila C Dollard; Jeffrey N Martin
Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertension.
AIDS (London, England) 2008;22(7):825-33.
2008: Elizabeth Sinclair; Rollie Ronquillo; Nicole Lollo; Steven G Deeks; Peter Hunt; Constantin T Yiannoutsos; Serena S Spudich; Richard W Price
Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):544-52.
2008: Richard W Price; Robin Parham; Jing Lu Kroll; Stephen A Wring; Brian Baker; Jeff Sailstad; Rebecca Hoh; Teri Liegler; Serena Spudich; Daniel R Kuritzkes; Steven G Deeks
Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin.
Antiviral therapy 2008;13(3):369-74.
2008: Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Y Hsue; Brinda Emu; Melissa R Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
The Journal of infectious diseases 2008;197(1):126-33.
2007: Annika C Karlsson; Joan M Chapman; B D Heiken; Rebecca Hoh; Esper Kallas; Jeffrey N Martin; Frederick Hecht; Steven G Deeks; Douglas F Nixon
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to Pol.
Journal of virology 2007;81(20):11543-8.
2007: Rachel E Owen; Elizabeth Sinclair; Brinda Emu; John W Heitman; Dale F Hirschkorn; C Lorrie Epling; Qi Xuan Tan; Brian Custer; Jeffery M Harris; Mark A Jacobson; Joseph M McCune; Jeffrey N Martin; Frederick Hecht; Steven G Deeks; Philip J Norris
Loss of T cell responses following long-term cryopreservation.
Journal of immunological methods 2007;326(1-2):93-115.
2007: Steven G Deeks; Bruce D Walker
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.
Immunity 2007;27(3):406-16.
2007: Stephen J Gange; Mari M Kitahata; Michael S Saag; david bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Hogg Robert; Michael Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
International journal of epidemiology 2007;36(2):294-301.
2007: Steven G Deeks; Jing Lu; Rebecca Hoh; Torsten B Neilands; George Beatty; Wei Huang; Teri Liegler; Peter Hunt; Jeffrey N Martin; Daniel R Kuritzkes
Interruption of enfuvirtide in HIV-1 infected adults with incomplete viral suppression on an enfuvirtide-based regimen.
The Journal of infectious diseases 2007;195(3):387-91.
2007: Steven G Deeks; Jeffrey N Martin
Partial treatment interruptions.
Current opinion in HIV and AIDS 2007;2(1):46-55.
2006: Serena S Spudich; Nicole Lollo; Teri Liegler; Steven G Deeks; Richard W Price
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
The Journal of infectious diseases 2006;194(12):1686-96.
2006: Peter W Hunt; Steven G Deeks
Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases?
The Journal of infectious diseases 2006;194(12):1632-4.
2006: Priscilla Y Hsue; Peter W Hunt; Elizabeth Sinclair; Barry M Bredt; Arlana Franklin; Maudi Killian; Rebecca Hoh; Jeffrey N Martin; Joseph M McCune; David D Waters; Steven G Deeks
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
AIDS (London, England) 2006;20(18):2275-83.
2006: Hiroyu Hatano; Peter Hunt; Jodi Weidler; Eoin Coakley; Rebecca Hoh; Teri Liegler; Jeffrey N Martin; Steven G Deeks
Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(10):1329-36.
2006: Peter W Hunt; P Richard Harrigan; Wei Huang; Michael Bates; David W Williamson; Joseph M McCune; Richard W Price; Serena S Spudich; Harry Lampiris; Rebecca Hoh; Teri Leigler; Jeffrey N Martin; Steven G Deeks
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia.
The Journal of infectious diseases 2006;194(7):926-30.
2006: Michelle Marcial; Jing Lu; Steven G Deeks; Rainer Ziermann; Daniel R Kuritzkes
Performance of human immunodeficiency virus type 1 gp41 assays for detecting enfuvirtide (T-20) resistance mutations.
Journal of clinical microbiology 2006;44(9):3384-7.
2006: Jing Lu; Steven G Deeks; Rebecca Hoh; George Beatty; Benjamin A Kuritzkes; Jeffrey N Martin; Daniel R Kuritzkes
Rapid emergence of enfuvirtide resistance in HIV-1-infected patients: results of a clonal analysis.
Journal of acquired immune deficiency syndromes (1999) 2006;43(1):60-4.
2006: Steven G Deeks
Antiretroviral treatment of HIV infected adults.
BMJ (Clinical research ed.) 2006;332(7556):1489.
2006: Steven G Deeks
The risk of treatment versus the risk of HIV replication.
Lancet 2006;367(9527):1955-6.
2006: Steven G Deeks; Becky Schweighardt; Terri Wrin; Justin Galovich; Rebecca Hoh; Elizabeth Sinclair; Peter Hunt; Joseph M McCune; Jeffrey N Martin; Christos J Petropoulos; Frederick Hecht
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.
Journal of virology 2006;80(12):6155-64.
2006: Kimberly A Jordan; Scott N Furlan; Veronica D Gonzalez; Annika C Karlsson; Maire Quigley; Steven G Deeks; Michael G Rosenberg; Douglas F Nixon; Johan K Sandberg
CD8 T cell effector maturation in HIV-1-infected children.
Virology 2006;347(1):117-26.
2006: Peter W Hunt; Steven G Deeks; david bangsberg; Andrew Moss; Elizabeth Sinclair; Teri Liegler; Michael Bates; Gabriel Tsao; Harry Lampiris; Rebecca Hoh; Jeffrey N Martin
The independent effect of drug resistance on T cell activation in HIV infection.
AIDS (London, England) 2006;20(5):691-9.
2006: Steven G Deeks
Challenges of developing R5 inhibitors in antiretroviral naive HIV-infected patients.
Lancet 2006;367(9512):711-3.
2006: david bangsberg; Edward P Acosta; Reena Gupta; David Guzman; Elise D Riley; P Richard Harrigan; Neil Parkin; Steven G Deeks
Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.
AIDS (London, England) 2006;20(2):223-31.
2006: Laurel E Nomura; Brinda Emu; Rebecca Hoh; Perry Haaland; Steven G Deeks; Jeffrey N Martin; Joseph M McCune; Douglas F Nixon; Holden T Maecker
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells.
AIDS research and therapy 2006;3():18.
2006: George Beatty; Peter Hunt; Anna Smith; Rebecca Hoh; Wei Huang; Jeff Martin; Steven G Deeks
A randomized pilot study comparing combination therapy plus enfuvirtide versus a treatment interruption followed by combination therapy plus enfuvirtide.
Antiviral therapy 2006;11(3):315-9.
2005: Peter V Chin-Hong; Steven G Deeks; Teri Liegler; Elilta Hagos; Melissa R Krone; Robert M Grant; Jeffrey N Martin
High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2005;40(4):463-71.
2005: Brinda Emu; Elizabeth Sinclair; David Favre; Walter J Moretto; Priscilla Hsue; Rebecca Hoh; Jeffrey N Martin; Douglas F Nixon; Joseph M McCune; Steven G Deeks
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
Journal of virology 2005;79(22):14169-78.
2005: Joan C Lo; Mahmood R Kazemi; Priscilla Y Hsue; Jeffrey N Martin; Steven G Deeks; Morris Schambelan; Kathleen Mulligan
The relationship between nucleoside analogue treatment duration, insulin resistance, and fasting arterialized lactate level in patients with HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1335-40.
2005: Steven G Deeks; Rebecca Hoh; Torsten B Neilands; Teri Liegler; Francesca T Aweeka; Christos J Petropoulos; Robert M Grant; Jeffrey N Martin
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.
The Journal of infectious diseases 2005;192(9):1537-44.
2005: Fatema A Legrand; Jacobo Abadi; Kimberly A Jordan; Miles P Davenport; Steven G Deeks; Glenn Fennelly; Andrew Wiznia; Douglas F Nixon; Michael G Rosenberg
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
AIDS (London, England) 2005;19(15):1575-85.
2005: Douglas F Nixon; Steven G Deeks; Barbara L Shacklett; Annika C Karlsson
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.
Lancet 2005;365(9475):1924-5.
2005: Serena S Spudich; Annelie C Nilsson; Nicole Lollo; Teri Liegler; Christos J Petropoulos; Steven G Deeks; Ellen Paxinos; Richard W Price
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
BMC infectious diseases 2005;5():98.
2004: Einar M Aandahl; Maire Quigley; Walter J Moretto; Markus Moll; Veronica D Gonzalez; Anders Sönnerborg; Stefan Lindbäck; Frederick Hecht; Steven G Deeks; Michael G Rosenberg; Douglas F Nixon; Johan K Sandberg
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
Blood 2004;104(12):3672-8.
2004: John Friend; Neil Parkin; Teri Liegler; Jeffrey N Martin; Steven G Deeks
Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen.
AIDS (London, England) 2004;18(14):1965-6.
2004: david bangsberg; Travis C Porco; C Kagay; Edwin D Charlebois; Steven G Deeks; David Guzman; Richard Clark; Andrew Moss
Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates.
The Journal of infectious diseases 2004;190(1):162-5.
2004: Annika C Karlsson; Sophie R Younger; Jeffrey N Martin; Zvi Grossman; Elizabeth Sinclair; Peter W Hunt; Elilta Hagos; Douglas F Nixon; Steven G Deeks
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
AIDS (London, England) 2004;18(7):981-9.
2004: Priscilla Y Hsue; Joan C Lo; Arlana Franklin; Ann F Bolger; Jeffrey N Martin; Steven G Deeks; David D Waters
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.
Circulation 2004;109(13):1603-8.
2004: Steven G Deeks; Bruce D Walker
The immune response to AIDS virus infection: good, bad, or both?
The Journal of clinical investigation 2004;113(6):808-10.
2004: Steven G Deeks; Jeffrey N Martin; Elizabeth Sinclair; Jeff Harris; Torsten B Neilands; Holden T Maecker; Elilta Hagos; Terri Wrin; Christos J Petropoulos; Barry M Bredt; Joseph M McCune
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.
The Journal of infectious diseases 2004;189(2):312-21.
2004: Richard W Price; Steven G Deeks
Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system.
Journal of neurovirology 2004;10 Suppl 1():44-51.
2003: Steven G Deeks
Treatment of antiretroviral-drug-resistant HIV-1 infection.
Lancet 2003;362(9400):2002-11.
2003: Annika C Karlsson; Jeffrey N Martin; Sophie R Younger; Barry M Bredt; Lorrie Epling; Rollie Ronquillo; Arjun Varma; Steven G Deeks; Joseph M McCune; Douglas F Nixon; Elizabeth Sinclair
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.
Journal of immunological methods 2003;283(1-2):141-53.
2003: david bangsberg; Edwin D Charlebois; Robert M Grant; Mark Holodniy; Steven G Deeks; Sharon Perry; Kathleen Nugent Conroy; Richard Clark; David Guzman; Andrew R Zolopa; Andrew Moss
High levels of adherence do not prevent accumulation of HIV drug resistance mutations.
AIDS (London, England) 2003;17(13):1925-32.
2003: Peter W Hunt; Steven G Deeks; Benigno Rodriguez; Hernan Valdez; Starley B Shade; Donald I Abrams; Mari M Kitahata; Melissa R Krone; Torsten B Neilands; Richard J Brand; Michael M Lederman; Jeffrey N Martin
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.
AIDS (London, England) 2003;17(13):1907-15.
2003: Donald I Abrams; Joan F Hilton; Roslyn J Leiser; Starley B Shade; Tarek Elbeik; Francesca T Aweeka; Neal L Benowitz; Barry M Bredt; Bradley W Kosel; Judith A Aberg; Steven G Deeks; Thomas F Mitchell; Kathleen Mulligan; Peter Bacchetti; Joseph M McCune; Morris Schambelan
Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial.
Annals of internal medicine 2003;139(4):258-66.
2003: Annika C Karlsson; Steven G Deeks; Jason D Barbour; Brandon D Heiken; Sophie R Younger; Rebecca Hoh; Meghan Lane-Fall; Matti Sällberg; Gabriel M Ortiz; James F Demarest; Teri Liegler; Robert M Grant; Jeffrey N Martin; Douglas F Nixon
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.
Journal of virology 2003;77(12):6743-52.
2003: Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry M Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.
The Journal of infectious diseases 2003;187(10):1534-43.
2003: Mark A Jacobson; Lea Liu; Hassan Khayam-Bashi; Steven G Deeks; Frederick Hecht; James Kahn
Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy.
AIDS (London, England) 2003;17(6):917-9.
2003: Steven G Deeks; Robert M Grant; Terri Wrin; Ellen Paxinos; Teri Liegler; Rebecca Hoh; Jeffrey N Martin; Christos J Petropoulos
Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.
AIDS (London, England) 2003;17(3):361-70.
2003: Peter A Anton; Ronald T Mitsuyasu; Steven G Deeks; David T Scadden; Bridget Wagner; Christine Huang; Catherine Macken; Douglas D Richman; Cindy Christopherson; Flavia Borellini; Richard Lazar; Kristen M Hege
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.
AIDS (London, England) 2003;17(1):53-63.
2002: Jason D Barbour; Terri Wrin; Robert M Grant; Jeffrey N Martin; Mark Segal; Christos J Petropoulos; Steven G Deeks
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.
Journal of virology 2002;76(21):11104-12.
2002: Jeannette M Whitcomb; Wei Huang; Kay Limoli; Ellen Paxinos; Terri Wrin; Gail Skowron; Steven G Deeks; Michael Bates; Nicholas S Hellmann; Christos J Petropoulos
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
AIDS (London, England) 2002;16(15):F41-7.
2002: Steven G Deeks; Bridget Wagner; Peter A Anton; Ronald T Mitsuyasu; David T Scadden; Christine Huang; Catherine Macken; Douglas D Richman; Cindy Christopherson; Carl H June; Richard Lazar; David F Broad; Sayeh Jalali; Kristen M Hege
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(6):788-97.
2002: JoAnn C Castelli; Steven G Deeks; Stephen Shiboski; Jay A Levy
Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals.
Blood 2002;99(11):4225-7.
2002: Steven G Deeks; Rebecca Hoh; Robert M Grant; Terri Wrin; Jason D Barbour; Amy Narvaez; Denise Cesar; Ken Abe; Mary Beth Hanley; Nicholas S Hellmann; Christos J Petropoulos; Joseph M McCune; Marc K Hellerstein
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.
The Journal of infectious diseases 2002;185(3):315-23.
2002: Steven G Deeks; Bernard Hirschel
Supervised interruptions of antiretroviral therapy.
AIDS (London, England) 2002;16 Suppl 4():S157-69.
2001: Steven G Deeks; PATRICIA CROVO; A Collier; A Smith; M Miller; I McGowan; Dion F Coakley
Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate.
Journal of acquired immune deficiency syndromes (1999) 2001;28(4):336-9.
2001: PATRICIA CROVO; Steven G Deeks; A Collier; S Safrin; Dion F Coakley; M Miller; Brian P Kearney; R L Coleman; PD Lamy; James O Kahn; I McGowan; Paul S Lietman
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.
Antimicrobial agents and chemotherapy 2001;45(10):2733-9.
2001: Richard W Price; Ellen Paxinos; Robert M Grant; B Drews; Annelie C Nilsson; Rebecca Hoh; Nicholas S Hellmann; Christos J Petropoulos; Steven G Deeks
Cerebrospinal fluid response to structured treatment interruption after virological failure.
AIDS (London, England) 2001;15(10):1251-9.
2001: Cheryl A Stoddart; Teri Liegler; F Mammano; Valerie Linquist-Stepps; Matthew Hayden; Steven G Deeks; Robert M Grant; F Clavel; Joseph M McCune
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.
Nature medicine 2001;7(6):712-8.
2001: ML Penn; M Myers; DA Eckstein; Teri Liegler; Matthew Hayden; F Mammano; F Clavel; Steven G Deeks; Robert M Grant; Mark A Goldsmith
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues.
AIDS research and human retroviruses 2001;17(6):517-23.
2001: Steven G Deeks
International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance.
Journal of acquired immune deficiency syndromes (1999) 2001;26 Suppl 1():S25-33.
2001: Steven G Deeks; Terri Wrin; Teri Liegler; Rebecca Hoh; Matthew Hayden; Jason D Barbour; Nicholas S Hellmann; Christos J Petropoulos; Joseph M McCune; Marc K Hellerstein; Robert M Grant
Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
The New England journal of medicine 2001;344(7):472-80.
2001: Teri Liegler; Matthew Hayden; K H Lee; Rebecca Hoh; Steven G Deeks; R M Granta
Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.
AIDS (London, England) 2001;15(2):179-84.
2001: Laura A Napolitano; Robert M Grant; Steven G Deeks; Diane Schmidt; S C De Rosa; L A Herzenberg; Brian G Herndier; J Andersson; Joseph M McCune
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis.
Nature medicine 2001;7(1):73-9.
2000: Ronald T Mitsuyasu; Peter A Anton; Steven G Deeks; David T Scadden; E Connick; M T Downs; A Bakker; MR Roberts; Carl H June; S Jalali; A A Lin; R Pennathur-Das; Kristen M Hege
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
Blood 2000;96(3):785-93.
2000: Steven G Deeks
Determinants of virological response to antiretroviral therapy: implications for long-term strategies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 2():S177-84.
2000: S S Huang; Jason D Barbour; Steven G Deeks; Jeannie S Huang; Robert M Grant; V L Ng; Joseph M McCune
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(3):504-10.
2000: Steven G Deeks; Jason D Barbour; Jeffrey N Martin; M S Swanson; Robert M Grant
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.
The Journal of infectious diseases 2000;181(3):946-53.
1999: Steven G Deeks; Nicholas S Hellmann; Robert M Grant; Neil Parkin; Christos J Petropoulos; M Becker; W Symonds; Margaret A Chesney; Paul A Volberding
Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.
The Journal of infectious diseases 1999;179(6):1375-81.
1999: Steven G Deeks; Frederick Hecht; M Swanson; Tarek Elbeik; Richard A Loftus; P T Cohen; Robert M Grant
HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.
AIDS (London, England) 1999;13(6):F35-43.
1999: Steven G Deeks; Robert M Grant
Sustained CD4 responses after virological failure of protease inhibitor-containing therapy.
Antiviral therapy 1999;4 Suppl 3():7-11.
1998: Steven G Deeks; PATRICIA CROVO; Paul S Lietman; F Hwang; Kenneth C Cundy; J F Rooney; Nicholas S Hellmann; S Safrin; James O Kahn
Safety, pharmacokinetics, and antiretroviral activity of intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults.
Antimicrobial agents and chemotherapy 1998;42(9):2380-4.
1998: Steven G Deeks; Robert M Grant; George Beatty; C Horton; Jill Detmer; S Eastman
Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.
AIDS (London, England) 1998;12(10):F97-102.
1998: Paul A Volberding; Steven G Deeks
Antiretroviral therapy for HIV infection: promises and problems.
JAMA : the journal of the American Medical Association 1998;279(17):1343-4.
1997: Steven G Deeks; A Collier; Jacob P Lalezari; A Pavia; D Rodrigue; W Lawrence Drew; J Toole; HS Jaffe; Andrew S Mulato; PD Lamy; W Li; Julie M Cherrington; Nicholas S Hellmann; J Kahn
The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.
The Journal of infectious diseases 1997;176(6):1517-23.
1997: Steven G Deeks; R L Coleman; R White; C Pachl; Morris Schambelan; David N Chernoff; Mark B Feinberg
Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.
The Journal of infectious diseases 1997;176(2):514-7.
1997: Steven G Deeks; M Smith; Mark Holodniy; James O Kahn
HIV-1 protease inhibitors. A review for clinicians.
JAMA : the journal of the American Medical Association 1997;277(2):145-53.
1997: Steven G Deeks; Paul A Volberding
HIV-1 protease inhibitors.
AIDS clinical review 1997;():145-85.
1995: Steven G Deeks; P Volberding
An approach to antiretroviral treatment of HIV disease. Combined antiretroviral therapy: the emerging role.
Hospital practice (1995) 1995;30 Suppl 1():23-31.